# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-039283
Filing Date
2023-08-11
Accepted
2023-08-11 16:11:39
Documents
75
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | brhc20057085_10q.htm iXBRL | 10-Q | 1496113
2 | EXHIBIT 31.1 | brhc20057085_ex31-1.htm | EX-31.1 | 6227
3 | EXHIBIT 31.2 | brhc20057085_ex31-2.htm | EX-31.2 | 6409
4 | EXHIBIT 32.1 | brhc20057085_ex32-1.htm | EX-32.1 | 4016
5 | EXHIBIT 32.2 | brhc20057085_ex32-2.htm | EX-32.2 | 4006
11 |  | image00007.jpg | GRAPHIC | 2588
| Complete submission text file | 0001140361-23-039283.txt |  | 6712157

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | erna-20230630.xsd | EX-101.SCH | 60668
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | erna-20230630_cal.xml | EX-101.CAL | 58092
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | erna-20230630_def.xml | EX-101.DEF | 269566
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | erna-20230630_lab.xml | EX-101.LAB | 708863
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | erna-20230630_pre.xml | EX-101.PRE | 415385
69 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc20057085_10q_htm.xml | XML | 880173

Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 231164210
SIC: 2834 Pharmaceutical Preparations